Burke Steven Keith insider trades
Burke Steven Keith has filed 17 Form 4s with the SEC that we hold, for Akebia Therapeutics, Inc. (AKBA) (SVP, Chief Medical Officer) and Scynexis INC (SCYX) (Director). Across all of them we count 0 purchases worth $0 and 20 sales worth $431.6K reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($94.0K). The largest single trade was a sale of 63,567 shares of Akebia Therapeutics, Inc. worth $68.0K, dated 2023-05-16. The first filing on our record is dated 2021-09-02 and the latest 2026-09-22.
Akebia Therapeutics, Inc. (AKBA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-31 | S, sale reported on Form 4 | 1,042 | $2.9K | 2021-09-02 |
| 2022-02-28 | S, sale reported on Form 4 | 7,400 | $15.9K | 2022-03-02 |
| 2022-03-01 | S, sale reported on Form 4 | 6,556 | $14.2K | 2022-03-02 |
| 2022-03-01 | S, sale reported on Form 4 | 1,100 | $2.4K | 2022-03-02 |
| 2022-08-31 | S, sale reported on Form 4 | 1,147 | $413 | 2022-09-01 |
| 2023-02-27 | S, sale reported on Form 4 | 7,539 | $6.1K | 2023-03-01 |
| 2023-03-01 | S, sale reported on Form 4 | 1,110 | $977 | 2023-03-03 |
| 2023-03-01 | S, sale reported on Form 4 | 6,400 | $5.6K | 2023-03-03 |
| 2023-03-01 | S, sale reported on Form 4 | 6,613 | $5.8K | 2023-03-03 |
| 2023-05-16 | S, sale reported on Form 4 | 63,567 | $68.0K | 2023-05-18 |
| 2023-08-25 | S, sale reported on Form 4 | 27,000 | $31.0K | 2024-05-09 |
| 2024-02-01 | S, sale reported on Form 4 | 24,311 | $40.8K | 2024-02-02 |
| 2024-02-27 | S, sale reported on Form 4 | 8,367 | $12.7K | 2024-02-29 |
| 2024-02-29 | S, sale reported on Form 4 | 7,169 | $11.3K | 2024-03-01 |
| 2025-02-03 | S, sale reported on Form 4 | 23,270 | $48.9K | 2025-02-04 |
| 2025-02-03 | S, sale reported on Form 4 | 27,236 | $57.2K | 2025-02-04 |
| 2025-03-03 | S, sale reported on Form 4 | 7,144 | $13.1K | 2025-03-04 |
| 2026-02-02 | S, sale reported on Form 4 | 25,375 | $35.3K | 2026-02-04 |
| 2026-02-02 | S, sale reported on Form 4 | 21,582 | $30.0K | 2026-02-04 |
| 2026-02-02 | S, sale reported on Form 4 | 20,701 | $28.8K | 2026-02-04 |
Scynexis INC (SCYX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1619834) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms